FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> flu vaccine | universal flu vaccine | H1N1

H1N1 provides new universal flu vax hope

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!


Thanks to the H1N1 flu virus, researchers may have found a key to developing a universal flu vaccine. According to a University of Chicago and Emory University study, people infected with H1N1 in 2009 developed antibodies to other flu strains. So, researchers believe that when given the correct immunogen, the body's immune system should stave off multiple flu strains.

"What is really new here is that there was a quantitation of how many of those cross reactive antibodies were made," said Peter Palese, chair of the microbiology department at Mount Sinai School of Medicine, to PBS. "It's very encouraging that people, humans, can make such antibodies in large quantities."

But study author Patrick Wilson still warns that a universal vaccine could be five to 10 years down the road. Still, the research provides valuable information, as the antibodies developed from the 2009 H1N1 strain attack the stalk of the virus, which is generally unchanged in various flu strains.

- see the PBS coverage

Related Articles:
Fauci outlines R&D challenges to universal flu vaccine
Universal flu vaccine protects mice in Mt. Sinai study
Feds earmark $2B for new, faster vaccine tech
WHO says H1N1 pandemic has run its course

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about H1N1   flu vaccine   universal flu vaccine